Skip to main content

Show 13 results Show all

DMPA-SC Advocacy Pack

Tools for advocacy and communications to increase contraceptive access and options

DMPA-SC is transforming contraceptive access, use, and choice for women and adolescent girls. Advocates play an important role in making sure their country’s policies and funding support access to a broad method mix, including options like DMPA-SC and self-injection.

The Injectable Access Collaborative’s DMPA-SC Advocacy Pack is designed to accelerate your advocacy efforts. It consists of evidence-based materials for advocates to use both for their own strategy development and for direct advocacy with decision-makers. Available in English and French in PDF, Word, and PowerPoint formats, materials are customizable and unbranded so that you can tailor them to your country context. Advocacy Pack for Subcutaneous DMPA. Product brand name Sayana Press.

Institutional author(s): PATH, Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, JSI
Publication date: December, 2023

Common terms for DMPA injectable contraception

This DMPA-SC Advocacy Pack brief helps you understand the terms surrounding DMPA injectables to inform your messaging and communication.

Institutional author(s): PATH, Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, JSI
Publication date: 2023

An overview of DMPA-SC: Injectable contraception that expands access and options

This DMPA-SC Advocacy Pack brief offers quick facts on the benefits of DMPA-SC; the product’s potential for empowering women and adolescent girls; the product’s availability; and how subcutaneous DMPA is different from intramuscular DMPA (DMPA-IM).

Institutional author(s): PATH, Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, JSI
Publication date: 2023

Evidence at-a-glance: What we know about DMPA-SC, a novel injectable contraceptive

These DMPA-SC Advocacy Pack briefs outline existing evidence on DMPA-SC grouped into top-line messages featuring data from different countries. Several “spotlight” handouts on specific topics can be paired with the summary brief as needed. All handouts can be printed and distributed directly to decision-makers.

Institutional author(s): PATH
Publication date: 2023

The case for DMPA-SC

Using simple messages, this DMPA-SC Advocacy Pack case statement describes reasons why DMPA-SC is a valuable and game-changing addition to a broad contraceptive method mix.

Institutional author(s): PATH, Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, JSI
Publication date: 2023

DMPA-SC key facts: Answering questions and dispelling common myths

This DMPA-SC Advocacy Pack brief offers concise, evidence-based information to help answer common questions and dispel myths about injectable contraception.

Institutional author(s): PATH, Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, JSI
Publication date: 2023

Slide template: Expanding options and access with DMPA-SC

This customizable slide deck template from the DMPA-SC Advocacy Pack provides a brief description of DMPA-SC and its benefits; an overview of evidence on how the product expands access through multiple delivery channels; and illustrative policy and advocacy gaps and recommendations for country decision-makers. Available in PowerPoint and PDF formats.

Institutional author(s): PATH
Publication date: 2023

Contraceptive Technology Innovation (CTI) Exchange

The Contraceptive Technology Innovation (CTI) Exchange is a platform for increasing global access to resources on contraceptive research, development, registration, and introduction through collaboration and knowledge sharing. The site features Calliope, the Contraceptive Pipeline Database, which provides information on new and future contraceptive products, including long-acting and novel products currently only available in limited markets.

Institutional author(s): FHI 360
Publication date: 2021

Tool Web page

WHO’s Essential Medicines and Health Products Information Portal

This website portal serves as a repository for full-text articles about all aspects of international drug and health product registration.

Institutional author(s): World Health Organization (WHO)
Publication date: December, 2020

Web page

Resources: A list of references about subcutaneous DMPA

This brief lists key references and resources from the evidence base on DMPA-SC. Pair this with the Evidence at-a-glance brief if your target decision-maker would like to have access to the data in that handout.

Institutional author(s): PATH
Publication date: October, 2019